BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35226354)

  • 1. A human blood-arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: Comparison with dog and pig in absolute abundance.
    Uchida Y; Takeuchi H; Goto R; Braun C; Fuchs H; Ishiguro N; Takao M; Tano M; Terasaki T
    J Neurochem; 2022 Apr; 161(2):187-208. PubMed ID: 35226354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes.
    Uchida Y; Goto R; Takeuchi H; Łuczak M; Usui T; Tachikawa M; Terasaki T
    Drug Metab Dispos; 2020 Feb; 48(2):135-145. PubMed ID: 31771948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs.
    Takeuchi H; Suzuki M; Goto R; Tezuka K; Fuchs H; Ishiguro N; Terasaki T; Braun C; Uchida Y
    Pharm Res; 2022 Jul; 39(7):1393-1413. PubMed ID: 35488144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
    Zhang Z; Tachikawa M; Uchida Y; Terasaki T
    Mol Pharm; 2018 Mar; 15(3):911-922. PubMed ID: 29436232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.
    Zhang Z; Uchida Y; Hirano S; Ando D; Kubo Y; Auriola S; Akanuma SI; Hosoya KI; Urtti A; Terasaki T; Tachikawa M
    Mol Pharm; 2017 Nov; 14(11):3729-3738. PubMed ID: 28954515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative targeted absolute proteomics of rat blood-cerebrospinal fluid barrier transporters: comparison with a human specimen.
    Uchida Y; Zhang Z; Tachikawa M; Terasaki T
    J Neurochem; 2015 Sep; 134(6):1104-15. PubMed ID: 25951748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells.
    Dehouck MP; Tachikawa M; Hoshi Y; Omori K; Maurage CA; Strecker G; Dehouck L; Boucau MC; Uchida Y; Gosselet F; Terasaki T; Karamanos Y
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
    Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T
    Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice.
    Uchida Y; Tachikawa M; Obuchi W; Hoshi Y; Tomioka Y; Ohtsuki S; Terasaki T
    Fluids Barriers CNS; 2013 Jun; 10(1):21. PubMed ID: 23758935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex, Organ, and Breed Differences in the mRNA Expression of Drug Transporters in the Liver and Kidney of Pigs.
    Kojima M; Degawa M
    Biol Pharm Bull; 2022; 45(4):508-516. PubMed ID: 35370276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood-Brain Barriers at Different Cerebral Regions and the Blood-Spinal Cord Barrier in Humans and Rats.
    Uchida Y; Yagi Y; Takao M; Tano M; Umetsu M; Hirano S; Usui T; Tachikawa M; Terasaki T
    Mol Pharm; 2020 Jun; 17(6):2006-2020. PubMed ID: 32310660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental changes in transporter and receptor protein expression levels at the rat blood-brain barrier based on quantitative targeted absolute proteomics.
    Omori K; Tachikawa M; Hirose S; Taii A; Akanuma SI; Hosoya KI; Terasaki T
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):117-123. PubMed ID: 31974045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Determination of Luminal and Abluminal Membrane Distributions of Transporters in Porcine Brain Capillaries by Plasma Membrane Fractionation and Quantitative Targeted Proteomics.
    Kubo Y; Ohtsuki S; Uchida Y; Terasaki T
    J Pharm Sci; 2015 Sep; 104(9):3060-8. PubMed ID: 25703048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier.
    Yasuda K; Cline C; Vogel P; Onciu M; Fatima S; Sorrentino BP; Thirumaran RK; Ekins S; Urade Y; Fujimori K; Schuetz EG
    Drug Metab Dispos; 2013 Apr; 41(4):923-31. PubMed ID: 23298861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood-Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ.
    Masuda T; Hoshiyama T; Uemura T; Hirayama-Kurogi M; Ogata S; Furukawa A; Couraud PO; Furihata T; Ito S; Ohtsuki S
    Mol Pharm; 2019 May; 16(5):2162-2171. PubMed ID: 30983357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood-Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats.
    Yaguchi Y; Tachikawa M; Zhang Z; Terasaki T
    Mol Pharm; 2019 May; 16(5):2021-2027. PubMed ID: 30977661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.
    Shawahna R; Uchida Y; Declèves X; Ohtsuki S; Yousif S; Dauchy S; Jacob A; Chassoux F; Daumas-Duport C; Couraud PO; Terasaki T; Scherrmann JM
    Mol Pharm; 2011 Aug; 8(4):1332-41. PubMed ID: 21707071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abundance of
    Brukner AM; Billington S; Benifla M; Nguyen TB; Han H; Bennett O; Gilboa T; Blatch D; Fellig Y; Volkov O; Unadkat JD; Ekstein D; Eyal S
    Mol Pharm; 2021 Jun; 18(6):2263-2273. PubMed ID: 34008992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood-Brain Barrier of Human Brain and Glioblastoma.
    Bao X; Wu J; Xie Y; Kim S; Michelhaugh S; Jiang J; Mittal S; Sanai N; Li J
    Clin Pharmacol Ther; 2020 May; 107(5):1116-1127. PubMed ID: 31664714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.
    Miyauchi E; Tachikawa M; Declèves X; Uchida Y; Bouillot JL; Poitou C; Oppert JM; Mouly S; Bergmann JF; Terasaki T; Scherrmann JM; Lloret-Linares C
    Mol Pharm; 2016 Aug; 13(8):2631-40. PubMed ID: 27347605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.